Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early methylprednisolone after recanalization for acute large vessel occlusion stroke
ChiCTR2500102515Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke and Large-Vessel Ischemic Stroke (LVO) comparing Endovascular treatment plus methylprednisolone group with Endovascular treatment plus placebo group (2 arms). Primary endpoints: Change in 90-day modified Rankin Scale score, All-cause mortality and 1 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
ischemic strokeLarge-Vessel Ischemic Stroke (LVO)
Beyond the preview
Go deeper on ChiCTR2500102515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102515.